NCT07232342

Brief Summary

This study aims to evaluate the prognostic significance of CLI in predicting 28-day mortality and other outcomes in critically ill patients who develop post-operative abdominal sepsis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Dec 2025Oct 2026

First Submitted

Initial submission to the registry

November 14, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

December 10, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

November 18, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

November 14, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

PeritonitisCapillary Leak IndexConventional BiomarkersCritically Ill Patients

Outcome Measures

Primary Outcomes (1)

  • all-cause mortality

    From 1-10-2025 to 1-10-2026

Study Arms (1)

adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay o

Diagnostic Test: Capillary Leak Index Versus

Interventions

Blood samples will be collected at three time points: within 1-2 hours of ICU admission (Day 0), Day 1, Day 2 and Day 7, to monitor trends in CLI and conventional biomarkers during the ICU stay. • CR

adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay o

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adult patients admitted to the ICU with post-operative secondary peritonitis requiring an ICU stay of at least 48 hours will be enrolled.

You may qualify if:

  • Age ≥ 18 years.
  • Postoperative secondary peritonitis requiring ICU admission, with clinical evidence of:
  • Diffuse or localized abdominal pain/tenderness. Peritoneal signs (e.g., guarding, rigidity, rebound tenderness). Imaging or intraoperative confirmation of purulent/exudative intra-abdominal fluid.
  • Systemic inflammation (e.g., fever, leukocytosis, or vasopressor requirement). Sepsis diagnosis per Sepsis-3 criteria: Suspected/confirmed infection with acute increase in SOFA score ≥2 points (6).
  • Anticipated ICU stay ≥48 hours postoperatively.

You may not qualify if:

  • Pregnancy
  • Advanced liver disease (Child-Pugh class B or C) that might independently affect albumin levels
  • Advanced kidney disease (CKD stage 4 or 5) or patients on chronic dialysis
  • Expected mortality within 48 hours of ICU admission
  • Patients with primary peritonitis or tertiary peritonitis
  • Immunocompromised patients (e.g., on chronic immunosuppressive therapy, solid organ transplant recipients, patients with HIV and CD4 count \<200/mm³)
  • Patients with pre-existing systemic inflammatory diseases that might affect baseline CRP levels
  • Patients participating in interventional trials that might affect outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benha University Hospital

Banhā, Qalyubia Governorate, 13511, Egypt

RECRUITING

MeSH Terms

Conditions

Peritonitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsPeritoneal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 18, 2025

Study Start

December 10, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

November 18, 2025

Record last verified: 2025-11

Locations